Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot, Leon A. Adams
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 5, pp. 774-774
Open Access | Times Cited: 565

Showing 1-25 of 565 citing articles:

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi, Deirdre B Blissett, Robert Blissett, et al.
Hepatology (2016) Vol. 64, Iss. 5, pp. 1577-1586
Open Access | Times Cited: 1124
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen, Manal F. Abdelmalek, Shelby Sullivan, et al.
Journal of Hepatology (2018) Vol. 68, Iss. 5, pp. 1063-1075
Open Access | Times Cited: 781
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict, Xuchen Zhang
World Journal of Hepatology (2017) Vol. 9, Iss. 16, pp. 715-715
Open Access | Times Cited: 692
Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 60-78
Open Access | Times Cited: 527
Molecular pathways of nonalcoholic fatty liver disease development and progression
Fernando Bessone, María Valeria Razori, Marcelo G. Roma
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 1, pp. 99-128
Closed Access | Times Cited: 470
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, et al.
Advances in Therapy (2017) Vol. 34, Iss. 6, pp. 1291-1326
Open Access | Times Cited: 465
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper, Anna Martin, Sonja Lang, et al.
Clinical Research in Cardiology (2020) Vol. 110, Iss. 7, pp. 921-937
Open Access | Times Cited: 461
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk, Danping Zheng, Oren Shibolet, et al.
EMBO Molecular Medicine (2018) Vol. 11, Iss. 2
Open Access | Times Cited: 444
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 443
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
Pieter Ruytinx, Paul Proost, Jo Van Damme, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 350
Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
Jenny Lee, Yasaman Vali, Jérôme Boursier, et al.
Liver International (2020) Vol. 41, Iss. 2, pp. 261-270
Open Access | Times Cited: 251
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 240
A new perspective on NAFLD: Focusing on lipid droplets
Eleonora Scorletti, Rotonya M. Carr
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 934-945
Open Access | Times Cited: 224
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 222
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 184
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 36, pp. 6571-6592
Open Access | Times Cited: 182
NAFLD and liver transplantation: Disease burden, current management and future challenges
Patrizia Burra, Chiara Becchetti, Giacomo Germani
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100192-100192
Open Access | Times Cited: 180
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, et al.
Medicine (2018) Vol. 97, Iss. 13, pp. e0214-e0214
Open Access | Times Cited: 179
Nutritional Importance of Carotenoids and Their Effect on Liver Health: A Review
Laura Inés Elvira-Torales, Javier García‐Alonso, María Jesús Periago
Antioxidants (2019) Vol. 8, Iss. 7, pp. 229-229
Open Access | Times Cited: 179
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
Eleonora Scorletti, Paul R. Afolabi, Elizabeth A. Miles, et al.
Gastroenterology (2020) Vol. 158, Iss. 6, pp. 1597-1610.e7
Open Access | Times Cited: 174
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 162
Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis
Stuart Astbury, Edmond Atallah, Amrita Vijay, et al.
Gut Microbes (2019) Vol. 11, Iss. 3, pp. 569-580
Open Access | Times Cited: 161
IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis
Debanjali Dasgupta, Yasuhiko Nakao, Amy S. Mauer, et al.
Gastroenterology (2020) Vol. 159, Iss. 4, pp. 1487-1503.e17
Open Access | Times Cited: 144
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
Lingxuan An, Ulrich Wirth, Dominik Koch, et al.
Journal of Gastrointestinal Surgery (2021) Vol. 26, Iss. 3, pp. 671-683
Open Access | Times Cited: 128
Defining comprehensive models of care for NAFLD
Jeffrey V. Lazarus, Quentin M. Anstee, Hannes Hagström, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 717-729
Closed Access | Times Cited: 107
Page 1 - Next Page

Scroll to top